STOCK TITAN
  1. Home
  2. News
  3. BMY

Bristol-Myers Squibb Co. - BMY STOCK NEWS

IMPACT
SENTIMENT
BMY : NYSE PFE : NYSE
Retrospective Observational Study Assessing Real-World Clinical Impact of Switching or Continuing Eliquis® or Rivaroxaban Presented at the European Society of Cardiology (ESC) Congress 2023
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb Shares Progress Toward Its Environmental, Social, and Governance Initiatives and Its Health Equity Commitments
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as an Adjuvant Treatment for Patients with Completely Resected Stage IIB or IIC Melanoma
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb to Showcase Data Across its Innovative Cardiovascular Portfolio at the European Society of Cardiology Congress 2023
IMPACT
SENTIMENT
BMY : NYSE
Updated Data from TRIDENT-1 Trial Show Durable Efficacy Benefits with Repotrectinib for Patients with Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
IMPACT
SENTIMENT
BMY : NYSE
Viz.ai Receives First De Novo Approval by the FDA for Hypertrophic Cardiomyopathy AI Algorithm
AI
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb Enters Into $4 Billion Aggregate Accelerated Share Repurchase Agreements
buyback
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb Launches Clear Understanding Campaign to Reveal the Plain Truth About Living with Moderate to Severe Plaque Psoriasis
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
earnings
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) as an Adjuvant Treatment for Patients with Completely Resected Stage IIB or IIC Melanoma
Stock BMY logo
Bristol-Myers Squibb Co.

NYSE:BMY

BMY Rankings

#119 Ranked by Market Cap
#4058 Ranked by Stock Gains
#655 Ranked by Dividends

BMY Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
New York

About BMY

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.